Prelude Therapeutics Inc
Ticker: PRLD
| Insider | Title |
|---|---|
| Advisors Llc Orbimed | Director, 10% or greater ownership |
| Andrew Combs | Chief Chemistry Officer |
| Brian Piper | Chief Financial Officer |
| Bros. Advisors (gp) Llc Baker | Director, 10% or greater ownership |
| Bros. Advisors Lp Baker | Director, 10% or greater ownership |
| Brothers Life Sciences Lp Baker | Director, 10% or greater ownership |
| Bryant David Lim | CLO, Interim CFO, Corp Sec. |
| Capital Gp Vi Llc Orbimed | Director, 10% or greater ownership |
| Capital Llc Orbimed | Director, 10% or greater ownership |
| Christopher Pierce | EVP and Chief of Business Oper |
| David J Mauro | Chief Medical Officer |
| David P Bonita | Director, 10% or greater ownership |
| Deborah Morosini | EVP, Chief of Clinical Affairs |
| Felix Baker | Director, 10% or greater ownership |
| Jane Huang | President, CMO |
| Julian Baker | Director, 10% or greater ownership |
| Krishna Vaddi | CEO, Director |
| L.p. 667, | Director, 10% or greater ownership |
| Laurent Chardonnet | Chief Financial Officer |
| Mardi Dier | Director |
| Martin Babler | Director |
| Paul A Friedman | Director |
| Peggy Scherle | Chief Scientific Officer |
| Victor Sandor | Director |